Lifecore Biomedical Inc (LFCR)
7.31
+0.33
(+4.73%)
USD |
NASDAQ |
Nov 22, 16:00
7.29
-0.02
(-0.27%)
After-Hours: 20:00
Lifecore Biomedical Revenue (Annual): 128.26M for May 31, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
May 31, 2024 | 128.26M |
May 31, 2023 | 103.27M |
May 31, 2022 | 111.27M |
May 31, 2021 | 100.87M |
May 31, 2020 | 160.07M |
May 31, 2019 | 557.56M |
May 31, 2018 | 524.23M |
May 31, 2017 | 469.78M |
May 31, 2016 | 476.92M |
May 31, 2015 | 539.26M |
May 31, 2014 | 476.81M |
May 31, 2013 | 441.71M |
May 31, 2012 | 317.55M |
May 31, 2011 | 276.73M |
May 31, 2010 | 238.22M |
Date | Value |
---|---|
May 31, 2009 | 235.94M |
May 31, 2008 | 238.53M |
May 31, 2007 | 210.50M |
May 31, 2006 | 231.95M |
May 31, 2005 | 205.23M |
May 31, 2004 | 192.09M |
May 31, 2003 | 112.26M |
October 31, 2002 | 183.16M |
October 31, 2001 | 190.88M |
October 31, 2000 | 197.16M |
October 31, 1999 | 21.45M |
October 31, 1998 | 33.50M |
October 31, 1997 | 9.50M |
October 31, 1996 | 2.10M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
100.87M
Minimum
2021
160.07M
Maximum
2020
120.75M
Average
111.27M
Median
2022
Revenue (Annual) Benchmarks
AngioDynamics Inc | 303.91M |
Precision Optics Corp Inc | 19.10M |
Sage Therapeutics Inc | 86.46M |
Outset Medical Inc | 130.38M |
NovaBay Pharmaceuticals Inc | 14.73M |